Junquan Song
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
FAP upregulates PD-L1 expression in cancer-associated fibroblasts to exacerbate T cells dysfunction and suppress anti-tumor immunity.
Journal: Cancer letters
Published: July 16, 2024
CPT1C-positive cancer-associated fibroblast facilitates immunosuppression through promoting IL-6-induced M2-like phenotype of macrophage.
Journal: Oncoimmunology
Published: May 15, 2024
Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response.
Journal: Nature communications
Published: December 07, 2023
Immunosuppressive MFAP2+ cancer associated fibroblasts conferred unfavorable prognosis and therapeutic resistance in gastric cancer.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: July 24, 2023
LncRNA-CCAT5-mediated crosstalk between Wnt/β-Catenin and STAT3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activity.
Journal: Cancer communications (London, England)
Published: March 12, 2023
CPT1C promotes the potential of gastric cancer ovarian metastasis through up-regulating fatty acid oxidation.
Journal: Acta biochimica et biophysica Sinica
Published: May 20, 2022
Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer.
Journal: Frontiers in immunology
Published: April 14, 2022
Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction.
Journal: Molecular medicine (Cambridge, Mass.)
Published: November 14, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026